Gencove

New York, NY · Founded 2015 · Privately Held (backing)

Developer of a sequencing platform designed to make whole-genome sequencing fast, affordable, and actionable. Gencove is based in New York, NY and was founded in 2015. It was valued at $50 million at its later-stage round in Oct 2021, the last priced event on record. It has raised $16 million across 3 recorded rounds; the latest was a $9.8 million early-stage round in Oct 2021.

PMV mark · valuation
$50.0M
Oct 2026
Priced at
its later-stage round
Oct 2021
Total raised
$16.0M
Last round
Early Stage VC
Oct 2021
What is Gencove worth?
$50.0MPrivateMarketView mark · Oct 2026

Valued at $50.0M at its later-stage round, Oct 2021. Nothing has traded since.

Free account
More of Gencove with a free account
  • ·The complete investor list: 13 names
  • ·Watch Gencove: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Gencove funding history

3 rounds
DateRoundRaisedPost-money
Oct 2021Early Stage VC$9.8M▮
Feb 2021Seed Round$1.8M▮
Jan 2019Seed Round$2.7M▮
Unlock post-money valuations

Membership and data by Private Market View

Gencove valuation

Gencove was valued at $50 million at its later-stage round in Oct 2021. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Gencove raised?

Gencove has raised $16 million across 3 recorded rounds since 2019. The largest was a $9.8 million early-stage round in Oct 2021.

Gencove has filed 4 Form Ds with the SEC since 2019, most recently in Nov 2021 ($9.8 million sold to 8 investors).

How Gencove's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Gencove, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Gencove

What is Gencove worth?
Gencove is valued at $50.0M as of Oct 2026. Valued at $50.0M at its later-stage round, Oct 2021. Nothing has traded since.
How much has Gencove raised?
Gencove has raised $16.0M in total funding across 3 recorded rounds.
When did Gencove last raise?
Gencove last raised in Oct 2021 (Early Stage VC), raising $9.8M.